Predicting Individualized Outcomes for Deceased Kidney Donor Waitlisted Candidates and Recipients - Litvinovich, Igor; Ng, Yue-Harn; Chong, Kelly; Argyropoulos, Christos; Zhu, Yiliang (medRxiv, 2023)
Kidney transplantation remains the optimal treatment for end-stage kidney disease (ESKD). However, the persistent disparity between the demand and supply of deceased donor (DD) kidneys underscores the need for better tools to assess transplant outcomes and donor kidney quality. The current Kidney Allocation System (KAS) relies on the Kidney Donor Risk Index (KDRI) to quantify DD kidney quality, yet it combines allograft failure and patient death into a single outcome, limiting its accuracy.In this paper we present refined statistical models to predict post-transplantation risk, differentiating between allograft failure and patient death as competing risks. Using comprehensive data from the Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipient (OPTN/SRTR) for 2000-2017, our models incorporate biological and clinical factors instead of donor race, account for within-center clustering and between-center variation, and capture non-linear relationships between risk factors.Our results reveal distinct risk factors for allograft failure and patient death. These models provide more personalized risk estimates tailored to donor kidney quality and recipient characteristics, aiding shared decision-making on kidney acceptance. Comparisons with the original KDRI demonstrate the superiority of our separate models, with improved predictability and reduced bias. Our approach eliminates the need to conflate allograft failure and patient death, leading to more accurate risk assessment and better-informed decisions regarding kidney offers.In conclusion, our study underscores the importance of distinguishing between allograft failure and patient death in kidney transplant risk assessment. By offering more precise risk estimates, our models enhance the transparency and efficiency of kidney acceptance decisions, ultimately benefiting both transplant providers and candidates. We also provide a web-based tool to facilitate this process, promoting better outcomes in kidney transplantation.Key PointsImproved statistical models for kidney transplant risk assessment, separating the risks of allograft failure and patient death.Models provide more personalized risk estimates, outperforming the existing Kidney Donor Risk Index (KDRI).Models enhance transparency and accuracy in evaluating donor kidney quality, aiding both providers and candidates in decision-making.Research improves the efficiency of kidney acceptance processes, leading to more successful transplants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is supported by the Dialysis Clinic Inc. Grant #4130Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was considered exempt by the Human Research Protection Office of the University of New Mexico Health Sciences Center (submission ID 16-288)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesComprehensive data from the Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipient for 2000-2017 were used.